[1]李锋, 李新霞, 常彬等.RT-PCR技术检测石蜡包埋软组织肉瘤中染色体易位融合基因表达的分子诊断学意义 [J].中华医学杂志, 2004, 84(18):1-5.

[2]程虹, 金木兰, 李增山, 等.软组织与骨肿瘤病理学和遗传学[M].北京:人民卫生出版社, 2006:132-139, 159176, 231-236, 354-358.

[3]Sato O, Wada T, Kawai A, et al.Expression of Epidermal Growth Factor Receptor, ERBB2and KIT in Adult Soft Tissue Sarcomas:a clinicopathologic study of 281 cases[J].Cancer, 2005, 103(9):1881-1890.

[4]Borden E C, Baker L H, Bell R S, et al.Soft Tissue Sarcomas of Adults-State of the Translational Science[J]. Clinical Cancer Research, 2003, 9(6):1941-1956.

[5]Pfeifer J D, Hill D A, O'Sullivan M J, et al.Diagnostic gold standard for soft tissue tumours:morphology or molecular genetics?[J].Histopathology, 2000, 37(6): 485-500.

[6]Nilbert M, Meza-zepeda L A, Francis P, et al.Lessons from genetic profiling in soft tissue sarcomas[J].Acta

Orthop Scand Suppl, 2004, 75(311):35-50.

[7]Landanyi M, Bridge J A.Contribution of molecular genetic data to the classification of sarcomas[J].Hum Pathol, 2000, 31(5):532-538.

[8]Piccart-Gebhart M J, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2positive breast cancer[J].NEngl J Med, 2005, 353(16): 1659-1672.

[9]Romond E H, Perez E A, Bryant J, et al.Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer[J].N Engl J Med, 2005, 353(16): 1673-1684.

[10]Hirota S, Isozaki K, Moriyama Y, et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J].Science, 1998, 279(5350):577-580.

[11]Joensuu H, Roberts P J, Sarlomo-Rikala M, et al.Effect of the tyrosine kinase inhibitor STI571in a patient with a metastatic gastrointestinal stromal tumor[J].N Engl J Med, 2001, 344(14):1052-1056.

[12]Sawyers C L.Imatinib GIST keeps finding new indications:successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor[J].Clin Oncol, 2002, 20 (17):3568-3569.

[13]Foster H, Knox S, Ganti A K, et al. HER-2/neu overexpression detected by immunohistochemistry in soft tissue sarcomas[J].Am J Clin Oncol, 2003, 26(2):188191.

[14]Hornick J L, Fletcher C D.Immunohistochemical staining for KIT(CD117)in soft tissue sarcomas is very limited in distribution[J].Am J Clin Pathol, 2002, 117 (2):188-193.

[15]Potti A, Ganti A K, Foster H, et al.Immunohistochemical detection of HER-2/neu, c-Kit(CD117)and vascular endothelial growth factor(VEGF)overexpression in soft tissue sarcoma[J].Anticancer Res, 2004, 24 (1):333-338.

[16]Wurl P, Taubert H, Meye A, et al.Prognostic value of immunohistochemistry for p53in primary soft-tissue sarcomas:a multivariate analysis of five antibodies[J]. Cancer Res Clin Oncol, 1997, 123(9):502-508.

Received	Published
2010-01-20	2010-12-01
Issue Date
2024-10-24

选择文件类型/文献管理软件名称

选择包含的内容

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

本文二维码

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

参考文献

{{custom_fnGroup.title_cn}}

脚注

{{custom_ack.title_cn}}

基金

版权